Detalles de la búsqueda
1.
Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy.
Cancer;
129(11): 1662-1671, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905392
2.
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response.
FASEB J;
35(3): e21395, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33566371
3.
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Cell Immunol;
343: 103753, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395859
4.
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab.
Int J Cancer;
142(6): 1277-1284, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080213
5.
Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Adv Exp Med Biol;
937: 93-108, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27573896
6.
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial.
Clin Cancer Res;
30(5): 959-964, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109438
7.
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.
J Thorac Oncol;
18(9): 1146-1164, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331604
8.
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
J Exp Clin Cancer Res;
42(1): 120, 2023 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37170152
9.
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review.
Transl Lung Cancer Res;
11(5): 935-949, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35693274
10.
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.
Per Med;
19(5): 395-401, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801400
11.
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Cells;
11(20)2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291098
12.
Diagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience.
Diagnostics (Basel);
12(7)2022 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35885614
13.
NUPR1 interacts with eIF2α and is required for resolution of the ER stress response in pancreatic tissue.
FEBS J;
288(13): 4081-4097, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403797
14.
Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma.
Cancers (Basel);
13(11)2021 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34073720
15.
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design.
Clin Lung Cancer;
22(1): e63-e66, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32917522
16.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Cancer Treat Rev;
99: 102256, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261032
17.
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas.
Virchows Arch;
478(6): 1125-1134, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420836
18.
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.
Crit Rev Oncol Hematol;
160: 103300, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744362
19.
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.
Cancers (Basel);
13(10)2021 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067823
20.
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.] / L'oncologia mutazionale del carcinoma polmonare: marcatori molecolari, farmaci, condizioni negoziali ed esperienze in centri di riferimento nazionale.
Recenti Prog Med;
112(6): 419-437, 2021 06.
Artículo
en Italiano
| MEDLINE | ID: mdl-34128934